Paracetamol (acetaminophen) use during pregnancy does not appear to cause ADHD in children, according to the largest and most carefully controlled studies available. Earlier research suggested a link, but newer sibling-comparison designs show that the association likely came from shared family factors, not the medication itself. This is reassuring news for pregnant people managing pain or fever.
Where did the concern come from?
Headlines linking paracetamol in pregnancy to ADHD in children began appearing around 2014 and intensified after a 2019 NIH-funded study. That study, which analysed cord blood from 996 births in the Boston Birth Cohort, found that children with the highest levels of acetaminophen byproducts in their cord blood were roughly 2.9 times more likely to be diagnosed with ADHD by age nine [2]. The finding was widely reported and understandably alarming.
Several earlier cohort studies pointed in the same direction. A meta-analysis of eight prospective cohort studies (totalling about 244,940 participants) found a modest overall increased risk, particularly with prolonged use of 28 days or more (AAFP, 2024) [7].
The problem was not that these studies were poorly done. They asked a reasonable question and found a real statistical pattern. The problem was what they could not control for: the shared genetics and home environments of the families involved. A parent who takes paracetamol frequently during pregnancy may also have chronic pain, migraine, or other health conditions that themselves carry associations with neurodevelopmental outcomes in children. Without a way to separate the medication from the reasons for taking it, the correlation remained ambiguous.
If you are curious about whether ADHD traits run in your family, you can take a free ADHD screening quiz as a starting point for that conversation.
What does the newer research show?
The most important shift came from sibling-controlled studies, which compare children born to the same mother where one pregnancy involved paracetamol exposure and another did not. Because siblings share genetics and much of their home environment, this design strips away many of the confounding factors that earlier studies could not address.
The largest of these, published in JAMA in 2024, used Swedish national health registers covering over 2.4 million children born between 1995 and 2019. In standard analyses (without sibling controls), the researchers found a small increase in risk: a hazard ratio of 1.07 for ADHD in exposed children. But when they compared siblings, the association vanished entirely (hazard ratio 0.98, 95% confidence interval 0.94 to 1.02). There was also no dose-response pattern in the sibling analyses (Ahlqvist et al., 2024) [4].
A Norwegian sibling study of 26,613 children from the MoBa cohort found a similar result. Short-term paracetamol use (up to 28 days) showed no increased ADHD risk in sibling comparisons. Even for long-term use (29 days or more), the within-family hazard ratio dropped to 1.06 (95% CI 0.51 to 2.05), which is not statistically significant. The between-family estimate was much higher (2.77), which is exactly what you would expect if family-level factors, not the drug, were driving the association (Gustavson et al., 2021) [6].
"Acetaminophen use during pregnancy was not associated with children's risk of autism, ADHD, or intellectual disability in sibling control analysis. This suggests that associations observed in other models may have been attributable to familial confounding." Ahlqvist et al., JAMA, 2024 [4]
A 2025 umbrella review of nine systematic reviews (covering 40 primary studies) confirmed this conclusion. The review found that when studies properly adjusted for familial factors using sibling-controlled analyses, the increased risk of both ADHD and autism in offspring did not persist (Sheikh et al., 2025) [3]. Seven of the nine reviews themselves had cautioned that their findings were limited by potential confounding.
How do sibling-controlled studies work?
Observational studies could not separate medication effects from the underlying conditions that led mothers to take paracetamol.
Sibling-controlled studies are one of the strongest observational designs available when a randomised trial would be unethical or impractical. The core logic is straightforward: if paracetamol truly causes ADHD, then the sibling who was exposed during pregnancy should have higher ADHD rates than the sibling who was not. If both siblings have similar ADHD rates regardless of exposure, the original association was likely driven by something the siblings share, such as genetics or household environment.
This design controls for factors that are extremely difficult to measure in standard studies: parental mental health traits, genetic predisposition to both pain conditions and neurodevelopmental differences, socioeconomic stability, and environmental exposures in the home. The Swedish study was uniquely powerful because Sweden's national birth and prescription registers allowed researchers to track millions of sibling pairs with verified prescription data rather than relying solely on maternal recall (NIH, 2024) [1].
A 2025 clinical perspective reviewing the full body of evidence concluded that most studies reporting positive findings had important biases, including selection bias, inconsistent confounder adjustment, and unmeasured familial confounding. The authors stated that in utero exposure to acetaminophen "is unlikely to confer a clinically important increased risk of childhood ADHD or ASD" and that the current evidence "does not warrant changes to clinical guidelines" (Damkier et al., 2025) [5].
Correlation vs. causation: a quick analogy
Imagine you notice that children who eat more ice cream also get more sunburns. You could conclude that ice cream causes sunburns, but the real explanation is summer: hot weather drives both ice cream consumption and sun exposure. In the paracetamol studies, the "summer" equivalent is the family context. Parents with certain genetic profiles or health conditions may both use more paracetamol and have children with higher baseline ADHD risk. The sibling design essentially holds "summer" constant.
What does this mean for pregnant people?
Sibling-comparison and genetic designs now suggest that family factors, not paracetamol itself, explain the earlier associations.
Paracetamol remains the most commonly recommended option for managing pain and fever during pregnancy. Nonsteroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen can reduce amniotic fluid levels, particularly after 20 weeks of gestation, which is why clinicians generally advise against them during pregnancy. Paracetamol does not carry this risk.
That said, no medication during pregnancy should be used without thought. The general principle is to use the lowest effective dose for the shortest time needed. This is not because of ADHD risk specifically, but because it is good practice with any medication during pregnancy.
If you have been avoiding paracetamol because of earlier headlines and managing pain or fever without relief, this is worth discussing with your obstetrician or midwife. Untreated high fever during pregnancy carries its own risks, including potential effects on fetal development.
| Question for your clinician | Why it matters |
|---|---|
| Is paracetamol still the safest option for my pain or fever? | Confirms current guidance applies to your situation |
| How much and how often can I safely take it? | Establishes the lowest effective dose for your needs |
| Are there non-medication options I should try first? | Some conditions respond to rest, hydration, or physical therapy |
| Should I be concerned about any other medications I take? | Opens a broader conversation about prenatal medication safety |
| Does my family history of ADHD change anything about my care plan? | Addresses genetic risk factors separately from medication exposure |
What are the remaining limitations?
The evidence is reassuring, but it is honest to name what we still do not know. The Swedish study relied partly on prescription records and self-reported use during prenatal visits, which may not capture every instance of over-the-counter paracetamol use. Dosage data is limited in most studies. And while sibling designs control for many confounders, they cannot rule out every possible pregnancy-specific factor that might differ between siblings.
The 2025 umbrella review rated the overall confidence in the existing reviews as low to critically low using the AMSTAR 2 quality assessment tool (Sheikh et al., 2025) [3]. This does not mean the sibling-controlled findings are wrong. It means the broader body of literature has methodological weaknesses, and the strongest evidence (from sibling designs) consistently points toward no causal link.
Research into ADHD causes continues to evolve. Genetics play a substantial role. If you are interested in understanding whether ADHD is genetic, the evidence for heritability is far stronger than for any single prenatal exposure. Understanding how ADHD presents in women and how ADHD appears in children can also help families recognise patterns early.
What should you discuss with your obstetrician?
If you are pregnant or planning a pregnancy and have read alarming headlines about paracetamol, bring those concerns to your next appointment. Your clinician can help you weigh the evidence in the context of your specific health needs. Here are practical starting points:
- Share what you have read. Clinicians appreciate knowing what information is shaping your decisions, even if it turns out to be outdated.
- Ask about your specific situation. A person managing chronic migraine has different needs than someone with an occasional headache. The risk-benefit calculation is individual.
- Discuss family history. If ADHD runs in your family, that is worth mentioning, not because paracetamol will change the risk, but because early awareness can lead to earlier support for your child if needed.
- Do not stop medications without guidance. Abruptly discontinuing a prescribed medication during pregnancy can create its own risks. Always consult your prescriber first.
If you are an adult wondering whether you might have ADHD yourself, you can try our online ADHD self-test as a first step before speaking with a clinician.
Infographic: key points about paracetamol pregnancy adhd.
Each new study design addressed a weakness in the previous one, gradually clarifying the picture.
Frequently asked questions
Does paracetamol cause ADHD in children?
The best available evidence says no. The largest sibling-controlled study (2.4 million children) found no association between prenatal paracetamol exposure and ADHD when family-level factors were accounted for (Ahlqvist et al., 2024). Earlier studies that suggested a link did not adequately control for shared genetics and environment.
Why did earlier studies show a connection?
Earlier studies used standard cohort designs that compared unrelated families. Parents who use more paracetamol may have health conditions (chronic pain, migraine, infections) that themselves carry associations with neurodevelopmental outcomes. Without controlling for these family-level factors, the studies picked up a correlation that was not caused by the drug itself.
What is a sibling-controlled study?
A sibling-controlled study compares children born to the same mother, where one pregnancy involved the exposure (paracetamol) and another did not. Because siblings share genetics and home environment, this design isolates the effect of the medication from the effect of the family context.
Is paracetamol safe during pregnancy?
Paracetamol is generally considered the safest over-the-counter pain and fever option during pregnancy. NSAIDs like ibuprofen can affect amniotic fluid levels, especially after 20 weeks. As with any medication, use the lowest effective dose for the shortest time needed, and discuss your specific situation with your clinician.
Should I avoid paracetamol if ADHD runs in my family?
The current evidence does not support avoiding paracetamol based on family ADHD history. ADHD has strong genetic components, but prenatal paracetamol exposure does not appear to be a contributing factor. If ADHD runs in your family, early screening for your child can help ensure timely support.
How much paracetamol is considered safe in pregnancy?
Dosing guidance varies by country and individual health factors. In general, clinicians recommend using the lowest effective dose for the shortest duration. Your obstetrician or midwife can provide specific guidance based on your needs.
Did the 2019 cord blood study prove paracetamol causes ADHD?
No. The 2019 Boston Birth Cohort study found a correlation between higher cord blood acetaminophen levels and later ADHD diagnosis, but it could not establish causation (NIH, 2019). The study had 996 participants and could not control for family-level confounding. Larger, better-controlled studies published since then have not replicated a causal link.
What if I took paracetamol during a previous pregnancy?
The sibling-controlled evidence is reassuring: children exposed to paracetamol prenatally did not have higher ADHD rates than their unexposed siblings. If your child shows signs of attention or behavioural difficulties, those are worth discussing with a paediatrician regardless of medication history, because ADHD has many contributing factors, most of them genetic.
Are there alternatives to paracetamol for pain during pregnancy?
Non-medication approaches (rest, hydration, cold or warm compresses, physical therapy) can help with some types of pain. For fever, paracetamol remains the standard recommendation because untreated high fever during pregnancy carries its own risks. Always consult your clinician before switching to or adding any medication.
Does the dose of paracetamol matter?
The Swedish sibling study found no dose-response pattern: higher doses did not produce higher ADHD risk in sibling comparisons (Ahlqvist et al., 2024). This further supports the conclusion that the earlier observed associations were driven by confounding, not by the drug itself.
